Sean P. Duffy - 04 Nov 2026 Form 4 Insider Report for Omada Health, Inc. (OMDA)

SEC form
4
Accepted by SEC
06 Nov 2026, 16:38:28 UTC
Prior SEC filing
05 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Sean P. Duffy filed Form 4 for Omada Health, Inc. (OMDA) on 06 Nov 2026.

Key facts

  • This page summarizes Sean P. Duffy's Form 4 filing for Omada Health, Inc. (OMDA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Nov 2026, 16:38.

Change

  • Previous filing in this sequence was filed on 05 Oct 2026.
  • Current net transaction value: -$248,731.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002069522 Primary reporting owner

Duffy Sean P.

Relationship
Chief Executive Officer, Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Options Exercise

Transaction value
Shares
+12,944
Change %
+3.4%
Price
$5.82*
Shares after
395,538
Date
04 Nov 2026
Ownership
Direct
Footnotes
F1
OMDA transaction

Common Stock

Sale

Transaction value
-$248,731
Shares
-12,944
Change %
-3.3%
Price
$19.22
Shares after
382,594
Date
04 Nov 2026
Ownership
Direct
Footnotes
F1, F2
OMDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
851,659
Date
04 Nov 2026
Ownership
See footnote
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMDA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-12,944
Change %
-11%
Price
$0.000000*
Shares after
103,651
Date
04 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,944
Exercise price
$5.82
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the Reporting Person.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $19.11 to $19.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

Footnote F4

100% of the shares subject to the option are fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .